The ongoing clinical trial research report- “2019 Prostatic Intraepithelial Neoplasia Ongoing Clinical Trials Study” analyzes the current scenario of all active Prostatic Intraepithelial Neoplasia trials across the world. The report presents top level analysis of global Prostatic Intraepithelial Neoplasia clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Prostatic Intraepithelial Neoplasia trials landscape to assist users for effective long term strategy formulation to beat competition.
The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.
It also segments the Prostatic Intraepithelial Neoplasia clinical trials by- • Region (Asia Pacific, Europe, Middle East Africa and Americas) • Countries • Trial Phase • Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc) • Type of the trial (Interventional, Observational) • Sponsor Type (Companies, Universities, Government Bodies etc) • Enrollment across types, sponsor types, geographies, current status and phases
The report also identifies the potential drug candidates under development for treatment of Prostatic Intraepithelial Neoplasia on the basis of intervention type ongoing Prostatic Intraepithelial Neoplasia trials.
The research work is prepared through extensive and continuous research on Prostatic Intraepithelial Neoplasia trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage: • All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope. • Drug candidates currently being researched for administering Prostatic Intraepithelial Neoplasia patients are identified • The report includes panorama of ongoing Prostatic Intraepithelial Neoplasia clinical trials across the globe • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided • Companies and universities focusing on Prostatic Intraepithelial Neoplasia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status) • Average Enrollment number, insights into enrollment trends, company wise enrollment are included • Both interventional and observational studies are analyzed • News and latest developments for the past one year are presented in the report
Our reports have been used by over 10K customers, including:
The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech...
The Global Chromatography Software Market size is expected to reach $1.6 billion by 2027, rising at a market growth of 9.7% CAGR during the forecast period. Chromatography is the procedure of segregating various components of a mixture based on the relative amounts of every component or solute distributed between a moving fluid stream, known...
175 pages •
By The Business Research Company
• Oct 2021
Major players in the biosimulation market are Certara, Dassault Systèmes, Schrödinger Inc., Simulations Plus Inc., Rhenovia Pharma, Insilico Biotechnology AG, Genedata AG, Entelos Inc., Physiomics plc, Rosa & Co. LLC., In silico biosciences Inc., INOSIM Software, LeadInvent Technologies, Nuventra Pharma, and Archimedes. The global biosimulation...
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Drugs In Development, 2021, provides an overview of the Osteonecrosis (Musculoskeletal Disorders) pipeline landscape.Osteonecrosis is bone death caused...
Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Drugs In Development, 2021, provides an overview of the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape.Anaplastic oligoastrocytoma...
Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021 Summary According to the recently published report ’Metabotropic Glutamate Receptor 5 - Drugs In Development, 2021’; Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) pipeline Target constitutes close...
Diagnostic Imaging Density
Illicit Drug Use
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.